Machine Learning and Computational Insights into Nanoparticle-Based Drug Delivery

Authors

https://doi.org/10.48313/bic.vi.56

Abstract

Nanoparticle-based drug delivery systems have emerged as a promising strategy to overcome the limitations of conventional therapeutic approaches, including poor bioavailability, lack of target specificity, and systemic toxicity. The unique physicochemical properties of nanoparticles enable controlled drug release, enhanced targeting, and improved therapeutic efficacy. However, the design and optimization of these systems remain highly complex, requiring the integration of multiple physicochemical and biological parameters. In recent years, computational modeling and Machine Learning (ML) have gained significant attention as powerful tools to address these challenges. ML techniques facilitate the prediction of nanoparticle properties, optimization of formulation parameters, and analysis of nanoparticle–biological interactions. Moreover, data-driven approaches contribute to improved nanotoxicity assessment and more efficient drug delivery system design. This review provides a comprehensive overview of nanoparticle-based drug delivery, with a particular focus on computational methods, ML applications, available data sources, and recent case studies. Key challenges, including data scarcity, model interpretability, and reproducibility, are critically discussed. In addition, emerging trends such as personalized nanomedicine, generative artificial intelligence, and adaptive drug delivery systems are highlighted. Overall, the integration of ML with nanoparticle-based drug delivery offers a transformative pathway toward precision medicine, enabling the development of more effective, safe, and targeted therapeutic strategies.

Keywords:

Nanoparticle, Drug delivery, Machine learning, Computational modeling, Nanotoxicity prediction

References

  1. [1] Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016). Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chemical reviews, 116(4), 2602–2663. https://doi.org/10.1021/acs.chemrev.5b00346
  2. [2] Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018). Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: Pathways for translational development and commercialization. Frontiers in pharmacology, 9, 790. https://doi.org/10.3389/fphar.2018.00790
  3. [3] Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A., & Chen, P. (2013). Biocompatibility of engineered nanoparticles for drug delivery. Journal of controlled release, 166(2), 182–194. https://doi.org/10.1016/j.jconrel.2012.12.013
  4. [4] Bertrand, N., & Leroux, J. C. (2012). The journey of a drug-carrier in the body: An anatomo-physiological perspective. Journal of controlled release, 161(2), 152–163. https://doi.org/10.1016/j.jconrel.2011.09.098
  5. [5] Panyam, J., & Labhasetwar, V. (2012). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced drug delivery reviews, 64, 61–71. https://doi.org/10.1016/j.addr.2012.09.023
  6. [6] Hadiwinata, R. D., Zhang, R., Barmin, R. A., Kiessling, F., Lammers, T., & Pallares, R. M. (2026). Clinical translation and landscape of copper nanoparticles. Drug delivery and translational research. https://doi.org/10.1007/s13346-026-02094-w
  7. [7] Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012). Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. Journal of controlled release, 161(2), 175–187. https://doi.org/10.1016/j.jconrel.2011.09.063
  8. [8] Chen, X., & Mao, S. S. (2007). Titanium dioxide nanomaterials: Synthesis, properties, modifications, and applications. Chemical reviews, 107(7), 2891–2959. https://doi.org/10.1021/cr0500535
  9. [9] Torchilin, V. P. (2014). Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature reviews drug discovery, 13(11), 813–827. https://doi.org/10.1038/nrd4333
  10. [10] Tapeh, S. M. T., Baei, M. S., & Keshel, S. H. (2021). Synthesis of thermogel modified with biomaterials as carrier for hUSSCs differentiation into cardiac cells: Physicomechanical and biological assessment. Materials science and engineering: c, 119, 111517. https://doi.org/10.1016/j.msec.2020.111517
  11. [11] Nikzad, A. (2026). Polymeric nanoparticles for targeted drug delivery: An updated review. Nano nexus & applications, 1(1), 1–11. https://doi.org/10.48314/nna.vi.58
  12. [12] Pattni, B. S., Chupin, V. V, & Torchilin, V. P. (2015). New developments in liposomal drug delivery. Chemical reviews, 115(19), 10938–10966. https://doi.org/10.1021/acs.chemrev.5b00046
  13. [13] Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular pharmaceutics, 5(4), 505–515. https://doi.org/10.1021/mp800051m
  14. [14] Cornelio, O. M., & Teimurbaglou, F. R. (2026). Recent advances in nanoparticle-based targeted drug delivery systems: A comprehensive review. Nano nexus & applications, 1(1), 12–23. https://doi.org/10.48314/nna.vi.60
  15. [15] Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., … ., & Chan, W. C. W. (2014). Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS nano, 8(3), 2439–2455. https://doi.org/10.1021/nn406018q
  16. [16] Cohen, Y., Rallo, R., Liu, R., & Liu, H. H. (2013). In silico analysis of nanomaterials hazard and risk. Accounts of chemical research, 46(3), 802–812. https://doi.org/10.1186/s40580-025-00502-4%0A%0A
  17. [17] Li, H., Zhao, Y., & Xu, C. (2025). Machine learning techniques for lipid nanoparticle formulation. Nano convergence, 12(1), 35. https://doi.org/10.1186/s40580-025-00502-4
  18. [18] Chou, W. C., Canchola, A., Zhang, F., & Lin, Z. (2025). Machine learning and artificial intelligence in nanomedicine. Wiley interdisciplinary reviews: nanomedicine and nanobiotechnology, 17(4), e70027. https://doi.org/10.1002/wnan.70027
  19. [19] Zhang, J., Koneru, A., Sankaranarayanan, S. K. R. S., & Lilley, C. M. (2023). Graph neural network guided evolutionary search of grain boundaries in 2D materials. ACS applied materials & interfaces, 15(16), 20520–20530. https://doi.org/10.1021/acsami.3c01161
  20. [20] Niknejad, K., Sharifzadeh Baei, M., & Motallebi Tala Tapeh, S. (2018). Synthesis of metformin hydrochloride nanoliposomes: Evaluation of physicochemical characteristics and release kinetics. International journal of nano dimension, 9(3), 298–313. https://ijnd.tonekabon.iau.ir/article_659887.html
  21. [21] Babakhani, B., Houshani, M., Motalebi Tala Tapeh, S., Shoja Shafiee, M., & Heidari Keshel, S. (2019). The evaluation of antioxidant and anticancer activity of alfalfa extract on MCF7 cell line. Regeneration, reconstruction & restoration (triple r), 4(1), 9–14. https://doi.org/10.22037/rrr.v4i1.29646
  22. [22] Moghaddam, M. S., Kafshgari, L. A., Houshani, M., Bahari, A., Sadeghi, B., Tapeh, S. M. T., & Shokraei, E. (2024). The role of Fe-Nx/N/V3C2 nanoelectrocatalyst based on organometallic framework in oxygen reduction activity. International journal of industrial chemistry, 15(4), 1–8. https://doi.org/10.57647/j.ijic.2024.1504.24
  23. [23] Tala-Tapeh, S. M., Mahmoodi, N., & Vaziri, A. (2015). Synthesis of bis-chalcones based on 5, 5{’{}}-methylenebis (2-hydroxybenzaldehyde) and screening their antibacterial activity. Journal of applied chemistry, 9(32), 53–58.

Downloads

Published

2026-03-05

Issue

Vol. 3 No. 1 (2026): Biocompounds

Section

Articles

How to Cite

Mar Cornelio , O. . (2026). Machine Learning and Computational Insights into Nanoparticle-Based Drug Delivery. Biocompounds, 3(1), 13-20. https://doi.org/10.48313/bic.vi.56

Similar Articles

1-10 of 12

You may also start an advanced similarity search for this article.